FourThought Financial Partners’s Boston Scientific BSX Stock Holding History

FourThought Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$721K	Buy	11,497 +53	+0.5%	+$4.24K	0.06%	157
2025 Q4	$1.09M	Sell	11,444 -328	-3%	-$32.2K	0.09%	134
2025 Q3	$1.15M	Buy	11,772 +136	+1%	+$14.1K	0.1%	128
2025 Q2	$1.25M	Buy	11,636 +15	+0.1%	+$1.52K	0.12%	120
2025 Q1	$1.17M	Buy	11,621 +8,672	+294%	+$873K	0.12%	120
2024 Q4	$263K	Buy	+2,949	New	+$260K	0.03%	262
2023 Q3	–	Sell	-4,381	Closed	-$237K	–	314
2023 Q2	$237K	Sell	4,381 -1,125	-20%	-$58.8K	0.03%	291
2023 Q1	$275K	Sell	5,506 -725	-12%	-$34.2K	0.04%	261
2022 Q4	$288K	Buy	+6,231	New	+$270K	0.04%	253

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FourThought Financial Partners's BSX Position: Q1 2026 in Review

FourThought Financial Partners increased its Boston Scientific (BSX) stake by 0.46% in Q1 2026, buying an estimated $4.24K and bringing the position to 11,497 shares worth $721K. The position accounts for 0.06% of the portfolio, ranked #157.

FourThought Financial Partners first reported a position in BSX in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.25M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

FourThought Financial Partners held 11,497 shares of Boston Scientific worth $721K as of Q1 2026.
FourThought Financial Partners bought 53 Boston Scientific shares in Q1 2026, an estimated $4.24K.
Boston Scientific made up 0.06% of FourThought Financial Partners's portfolio in Q1 2026, its #157 holding.
FourThought Financial Partners first reported a position in Boston Scientific in Q4 2022 and has held it in 9 quarters since.
FourThought Financial Partners's Boston Scientific position peaked at $1.25M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.